Despite having been used widely for over a decade, alendronate and similar bisphosphonate drugs continue to inspire quite a bit of scientific research.

Pharmacologic Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women

Alendronate Linked to Heart Problems

Alendronate increases risk of dental complications

Effects of antifracture drugs in postmenopausal, male and glucocorticoid-induced osteoporosis--usefulness of alendronate and risedronate.

The Cost-effectiveness of Therapy With Teriparatide and Alendronate in Women With Severe Osteoporosis

Teriparatide alone is less cost-effective than alendronate alone for the treatment of women with severe osteoporosis

Spontaneous femoral shaft fracture after long-term alendronate.

Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats

The cost-effectiveness of alendronate in the management of osteoporosis

Treatment with alendronate plus calcium, alendronate alone, or calcium alone for postmenopausal low bone mineral density.

Teriparatide or alendronate in glucocorticoid-induced osteoporosis.

Effects of alendronate and hormone replacement therapy, alone or in combination, on bone mass in postmenopausal women with osteoporosis: a prospective, randomized study